Company Description
Royal Philips Electronics has its royal fingers in lots of different pies. It makes consumer electronics, including TVs, VCRs, DVD players, and fax...
Key Philips Electronics Financials
| Company Type | Public - NYSE: PHG; Euronext Amsterdam: PHI Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $39,463.4 |
| 2006 Employees | 391,948 |
More Philips Electronics Financials (11 pages)
Rankings
- Amsterdam Exchange 25
- Dow Jones STOXX 50
- Euronext 100
- #184 in FT Global 500
Competition
Competitive Landscape for Household Appliance Manufacture
Demand is driven by growth in consumer income and by home sales. The profitability of individual companies depends on efficient operations and effective marketing. Large companies have economies...
Read more about Philips Electronics's competition across multiple industries
Top Philips Electronics Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Philips Electronics Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Gerard Kleisterlee | Network | E-mail |
| EVP, CFO, and Director | Pierre-Jean Sivignon | Network | E-mail |
| CEO, Imaging Systems | Daniel Hartert | Network | E-mail |
More Philips Electronics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Philips Electronics News
- Siemens To Cut 16,750 Jobs Worldwide To Speed Up Cost Savings, Boost Margins [InvesTrend] (09 Jul 2008 00:01:00 EDT)
- Iterative method of determining a spatial distribution of values of a property [U.S. Patents] (08 Jul 2008 17:07:00 EDT)
- Wearable device for bioelectrical interaction with motion artifact correction means [U.S. Patents] (08 Jul 2008 17:07:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.







